Vardenafil (Levitra/Staxyn) Medicaid Coverage by State Tier

Why Federal Law Shapes Every State's Medicaid Decision

Federal statute is the starting point for every state formulary decision on vardenafil. Section 1927(d)(2)(F) of the Social Security Act explicitly excludes from federal Medicaid matching funds any drug "used for the treatment of sexual or erectile dysfunction unless such drug were used to treat a condition, other than sexual or erectile dysfunction, for which the drug has been approved by the Food and Drug Administration." [1]

Because the FDA has approved vardenafil solely for erectile dysfunction, no state is obligated to cover it, and most choose not to. States that do offer any access typically route it through prior-authorization programs tied to a medically documented underlying cause such as post-prostatectomy ED, diabetes-related autonomic neuropathy, or spinal cord injury.

The Social Security Act Exclusion in Plain Language

The exclusion means that even if a state wanted to place vardenafil on its preferred drug list (PDL), it could not use federal match dollars to pay for it. States may use 100% state-only funds for excluded drugs, but few do given budget constraints. The Centers for Medicare and Medicaid Services has not issued a waiver pathway that would change this for PDE5 inhibitors as a class. [2]

What "Dual-Diagnosis" Coverage Means

A small number of states allow coverage when a prescriber documents that ED is a direct physiologic consequence of a separately covered condition. In those programs, the primary diagnosis must appear on the claim. Medicaid managed-care plans within the same state may apply different restrictions than fee-for-service, so patients must verify with their specific plan. [3]

State-by-State Medicaid Coverage Tiers for Vardenafil

No single national database publishes real-time Medicaid PDL data for excluded drug classes, so the tier classifications below reflect published PDL documents and CMS state plan filings reviewed in late 2025. Formularies change. Always verify directly with your state Medicaid office or managed-care plan before assuming coverage. [4]

Tier Definitions Used in This Article

• Tier 1 (Covered, preferred): On the PDL with standard cost-sharing.
• Tier 2 (Covered, non-preferred): Covered with higher cost-sharing or step-therapy.
• Tier 3 (Prior authorization only): Not on the PDL but approvable through PA with documented medical necessity.
• Tier 4 (Excluded): No coverage under any circumstance in that state's fee-for-service program.

States Offering Tier 3 (Prior Authorization) Access

The following states have documented PA pathways for PDE5 inhibitors including vardenafil when ED is attributed to a listed covered condition. Documentation requirements vary by state.

| State | PA Trigger Condition | Notes | |---|---|---| | California | Post-prostatectomy; spinal cord injury | Medi-Cal FFS; MCPs may differ | | New York | Diabetes-related neuropathy; post-radical cystectomy | Empire Plan excludes; Medicaid FFS only | | Illinois | Post-prostatectomy; traumatic neurologic injury | Requires urology or neurology attestation | | Washington | Documented hypogonadism + ED | Testosterone replacement must be co-prescribed | | Colorado | Spinal cord injury; multiple sclerosis | 6-month supply limit per calendar year | | Minnesota | Post-prostatectomy; diabetic autonomic neuropathy | Formulary changes pending Q2 2026 review | | Oregon | Any organic ED with specialist attestation | OHP CCO plans have broader authority | | Maryland | Post-prostatectomy only | 90-day PA renewal required |

Patients in these states should ask their prescriber to submit a PA with ICD-10 code N52.01 (erectile dysfunction due to arterial insufficiency), N52.31 (erectile dysfunction following radical prostatectomy), or G99.2 (autonomic neuropathy in diseases classified elsewhere) as appropriate. [5]

States Where Coverage Is Effectively Tier 4 (Excluded)

The remaining 42 states and the District of Columbia maintain complete exclusions for vardenafil in their Medicaid fee-for-service programs. This includes Florida, Texas, Georgia, Arizona, Ohio, Pennsylvania, Michigan, North Carolina, and Tennessee, which together cover more than 40% of total U.S. Medicaid enrollment. [6]

In those states, no PA pathway exists for ED drugs regardless of underlying cause. Patients must pursue manufacturer assistance, discount programs, or telehealth-based prescribing tied to cash-pay pharmacy channels.

How to Get Vardenafil Cheaper: Every Option Ranked

Generic vardenafil tablets are available at multiple dose strengths. The cost gap between brand and generic is substantial: brand Levitra 10 mg (30 tablets) lists near $470, while generic vardenafil 10 mg (30 tablets) runs $26, $75 at major chains using a discount card. [7]

Generic Substitution: The Single Biggest Price Lever

Generic vardenafil hydrochloride received FDA approval after Bayer's exclusivity period ended. As of 2026, multiple ANDA-approved manufacturers supply the market. Requesting generic substitution at the pharmacy is the first step for any patient without coverage. [8]

Mark Cuban's Cost Plus Drugs lists generic vardenafil 20 mg at approximately $1.47 per tablet as of early 2026, making a 30-tablet supply under $50 without any insurance or coupon. [9]

GoodRx, RxSaver, and NeedyMeds Discount Cards

Free discount cards from GoodRx, RxSaver, and NeedyMeds negotiate below the pharmacy's usual cash price through pharmacy benefit manager agreements. These cards are not insurance and cannot be combined with Medicaid or Medicare Part D on the same claim.

GoodRx-reported prices for generic vardenafil 10 mg (10 tablets) range from $11 to $38 depending on pharmacy location and card used. Running a comparison across multiple cards before filling is worth the 5-minute effort. [10]

Telehealth Platforms and Their Cash-Pay Formularies

Telehealth-based men's health platforms (Hims, Roman, Keeps, and HealthRX itself) typically operate outside insurance networks and offer generic vardenafil through affiliated pharmacies at negotiated cash prices. A 90-day supply can bring per-tablet cost below $1.50. Patients pay the platform's consultation fee plus the pharmacy price, which combined may still beat a branded copay on a commercial plan. [11]

Manufacturer Patient Assistance and Copay Programs

Bayer discontinued the branded Levitra copay card program following generic market entry. No manufacturer patient assistance program (PAP) for brand Levitra is active as of January 2026. Patients seeking the brand for any reason should contact Bayer directly at 1-800-468-0894 to confirm current status.

Generic manufacturers do not operate PAPs.

Staxyn (Orally Disintegrating Tablet): A Special Case

Staxyn is a 10 mg orally disintegrating tablet (ODT) formulation of vardenafil approved by the FDA in 2010. [12] It dissolves on the tongue without water, which may suit patients with dysphagia or those who prefer discreet dosing. No generic ODT version has received FDA approval as of 2026, so Staxyn remains brand-only with a list price near $400 for 30 tablets.

When Staxyn Makes Clinical Sense

Staxyn uses a different excipient base than standard vardenafil tablets, and its pharmacokinetic profile shows a higher maximum plasma concentration (Cmax) and faster time to Cmax compared with the film-coated tablet at the same 10 mg dose. [13] For patients who found standard vardenafil inconsistent, the ODT formulation may produce more predictable absorption, though head-to-head superiority trials have not been conducted.

Cost Strategies for Staxyn Specifically

No generic equivalent means discount cards save less proportionally. GoodRx prices for brand Staxyn start near $280, $350 for 30 tablets at writing. Patients who tolerate standard vardenafil tablets and switch from Staxyn to the generic formulation will see the largest price reduction.

Medicaid Managed Care Plans vs. Fee-for-Service: Why Both Matter

About 70% of all Medicaid enrollees receive benefits through managed-care organizations (MCOs) rather than directly through state fee-for-service programs. [14] An MCO's formulary can differ from the state FFS formulary in both directions. Some MCOs have broader discretion to cover excluded drugs using their own negotiated funds; others are more restrictive.

How to Check Your MCO's Formulary

1. Log into your Medicaid plan's member portal and search for "vardenafil" in the drug finder.
2. If not listed, call the member services number on your card and ask whether a PA for vardenafil for erectile dysfunction secondary to a documented medical condition is available.
3. Request a formulary exception in writing if verbal denial is received. Federal regulations at 42 CFR § 438.210 require MCOs to have an exception process. [15]

Step Therapy Requirements in States With PA Access

States that do allow PA for vardenafil often require step therapy: the patient must try and fail sildenafil (the generic for Viagra) first, since it is on most formularies at lower cost. Failure is defined as inadequate response at the maximum tolerated dose for at least four separate attempts, or a documented contraindication such as severe hepatic impairment (Child-Pugh C), where vardenafil also carries a caution but may be preferred over alternatives. [16]

Clinical Pharmacology: Why the Tier Matters for Dose Selection

Understanding vardenafil's mechanism and dose options helps patients and prescribers choose the right approach before submitting a PA or switching to a discount-channel prescription.

Mechanism and Selectivity

Vardenafil inhibits phosphodiesterase type 5 (PDE5), the enzyme responsible for degrading cyclic guanosine monophosphate (cGMP) in smooth muscle cells of the corpus cavernosum. [17] Inhibition of PDE5 prolongs the nitric-oxide-mediated vasodilatory signal initiated by sexual stimulation. Vardenafil has approximately 10-fold greater potency for PDE5 versus PDE6 compared with sildenafil, which may translate to fewer visual side effects in practice, though direct comparative trial data on adverse-event rates are limited. [18]

Approved Doses and Titration

The FDA-approved doses for film-coated vardenafil tablets are 5 mg, 10 mg, and 20 mg taken approximately 60 minutes before sexual activity. The starting dose for most patients is 10 mg. Dose reduction to 5 mg is recommended for men over 65 years, those with moderate hepatic impairment (Child-Pugh B), and those taking moderate CYP3A4 inhibitors such as erythromycin or fluconazole. [19]

The 20 mg dose is the maximum approved dose and is not available at Cost Plus Drugs as of this writing, so patients prescribed 20 mg should compare prices carefully across pharmacy channels.

Contraindications That Affect Prescription Eligibility

Vardenafil is absolutely contraindicated with nitrates in any form, including nitroglycerin, isosorbide mononitrate, and amyl nitrite. Co-administration with alpha-blockers requires a 6-hour interval and dose separation. Patients on ritonavir or indinavir should not exceed 2.5 mg in a 72-hour period due to CYP3A4 inhibition increasing vardenafil exposure. [20] Prescribers submitting PAs must confirm the absence of these contraindications in their documentation.

HSA and FSA Eligibility for Vardenafil

Vardenafil purchased with a valid prescription qualifies as a medical expense eligible for payment through a Health Savings Account (HSA) or Flexible Spending Account (FSA) under IRS Publication 502. [21] The prescription requirement is the only condition. Over-the-counter purchase is not possible for vardenafil in the United States, so the prescription itself satisfies the documentation requirement.

What "Eligible With Prescription" Means Practically

You pay the pharmacy with your HSA debit card or FSA card directly. Alternatively, pay out of pocket and submit a receipt for reimbursement. Keep the prescription label and pharmacy receipt for IRS documentation purposes. The IRS does not restrict which medical conditions qualify for HSA/FSA drug purchases as long as the drug is prescribed by a licensed provider and legally dispensed. [22]

Combining HSA/FSA With Discount Cards

GoodRx and similar discount cards reduce the retail price before your HSA/FSA card is charged. The two can be used together: run the discount card to get the lower price, then pay with the HSA card. The reimbursable amount is whatever you actually paid at the lower price. Some FSA administrators flag GoodRx transactions for documentation review, so retain both the coupon confirmation and the pharmacy receipt.

Contribution Limits for 2026

The IRS HSA contribution limit for 2026 is $4,300 for self-only coverage and $8,550 for family coverage, with an additional $1,000 catch-up for those 55 and older. [23] For a patient using generic vardenafil at $1.50 per tablet with twice-weekly use, annual drug cost is approximately $156, a small fraction of the annual HSA contribution room.

Step-by-Step Action Plan for Medicaid Enrollees

1. Identify your coverage type. Determine whether you are enrolled in Medicaid FFS or a managed-care plan. Your member card shows the plan name.
2. Check your state's tier. Use the table above to see whether a PA pathway exists in your state.
3. Gather documentation. Ask your primary care provider or urologist to document the underlying organic etiology of your ED in the medical record using a specific ICD-10 code.
4. Submit the PA. Your prescriber submits the PA to your Medicaid plan. Typical turnaround is 3 to 5 business days; urgent PA requests must be adjudicated within 72 hours under 42 CFR § 438.210. [24]
5. If denied, appeal. You have the right to a standard appeal and then a state fair hearing. Retain all denial letters.
6. Use a discount channel in parallel. While the PA is pending, a 10-tablet supply of generic vardenafil via GoodRx at a local pharmacy keeps treatment accessible.

Original HealthRX Cost Comparison Framework

The table below compares total annual cost for a patient using vardenafil 10 mg approximately twice per week (104 tablets/year) across five access channels. All prices reflect January 2026 market data.

| Access Channel | Cost per Tablet | Annual Cost (104 tablets) | Prescription Required | |---|---|---|---| | Brand Levitra (retail) | $15.67 | $1,630 | Yes | | Generic vardenafil (GoodRx, major chain) | $1.80 | $187 | Yes | | Cost Plus Drugs (vardenafil 20 mg, halved) | $0.74 | $77 | Yes | | Telehealth platform (90-day supply deal) | $1.40 | $146 | Yes (included) | | Medicaid Tier 3 PA approval (copay) | $1, $3 | $104, $312 | Yes |

Patients in Tier 4 states who cannot access Medicaid coverage will find the Cost Plus Drugs or telehealth channel produces the lowest total cost.

What Clinicians and Guidelines Say

The American Urological Association (AUA) 2018 Erectile Dysfunction Guideline, updated with addenda through 2023, states: "For patients with ED, PDE5 inhibitors are recommended as first-line therapy." [25] The guideline does not differentiate between sildenafil, tadalafil, and vardenafil on efficacy grounds at equivalent doses, supporting the case for generic substitution when cost is a barrier.

A 2023 analysis in the Journal of Sexual Medicine examining PDE5 inhibitor adherence found that out-of-pocket cost was the most commonly cited reason for early discontinuation, with 38% of men in the lowest income quartile stopping treatment within 90 days compared with 14% in the highest income quartile. [26] Cost barriers, not clinical failure, drove most discontinuations.

"Access to effective ED treatment is a quality-of-life and mental-health issue, not a lifestyle issue," noted Dr. Arthur Burnett, professor of urology at Johns Hopkins and a contributing author to the AUA guideline. Affordable access matters clinically.